Bacterial type IV secretion systems (T4SS) are a highly diversified but evolutionarily 21 related family of macromolecule transporters that can secrete proteins and DNA into the 22 extracellular medium or into target cells. They have been long known to play a fundamental role 23 in bacterial conjugation and virulence of several species. It was recently shown that a subtype of 24 T4SS harboured by the plant pathogenic bacterium Xanthomonas citri transfers toxins into other 25 bacteria cells resulting in cell death. In this study, we show that a similar T4SS from the multi-26 drug-resistant global opportunistic pathogen Stenotrophomonas maltophilia is proficient in killing 27 competitor bacterial species. T4SS-dependent duelling between S. maltophilia and X. citri was 28 observed by time-lapse fluorescence microscopy. A bioinformatic search of the S. maltophilia 29 K279a genome for proteins containing a C-terminal domain (XVIPCD) conserved in X. citri T4SS 30 effectors identified eleven putative effectors secreted by the S. maltophilia T4SS. Six of these 31 effectors have no recognizable domain except for the XVIPCD. We selected one of these new 32 effectors (Smlt3024) and its cognate inhibitor (Smlt3025) for further characterization and 33 confirmed that Smlt3024 is indeed secreted in a T4SS-dependent manner by S. maltophilia when 34 in contact with a target bacterial species. Expression of Smlt3024 in the periplasm of E. coli 35 resulted in greatly reduced growth rate and cell size, which could be counteracted by co-expression 36 with its cognate periplasmic inhibitor, Smlt3025. This work expands our current knowledge about 37 the diverse function of T4SSs subtypes and increases the panel of effectors known to be involved 38 in T4SS-mediated interbacterial competition. Further elucidation of the mechanism of these 39 antibacterial proteins could lead to the discovery of new antibacterial targets. The study also adds 40 information about the molecular mechanisms possibly contributing to the establishment of S. 41 maltophilia in different biotic and abiotic surfaces in both clinical and environmental settings.
Results

137
Stenotrophomonas maltophilia VirB/T4SS induces target bacteria cell death 138 The genome of S. maltophilia K279a [32] harbours two clusters of genes encoding distinct 139 T4SSs: smlt1283-smlt1293 (annotated as trb) and smlt2997-smlt3008 (annotated as virB) [33] . 140 Comparative sequence analysis showed that the S. maltophilia virB1-11 and virD4 genes are most 141 closely related with their counterparts in X. citri involved in bacterial killing (37% -82% identity 142 at the amino acid level), with the three ATPases that energize the system presenting the greatest 143 levels of identity: VirB4 (81%), VirB11 (82%) and VirD4 (79%) (Fig. 1A) . Phylogenetic analysis 144 based on the amino acid sequences of S. maltophilia VirD4/Smlt3008 grouped the S. maltophilia 145 VirB/T4SS together with the X. citri VirB/T4SS involved in bacterial killing, while 146 Stenotrophomonas Trb/T4SS belongs to another group of T4SSs (S1 Fig) . The second T4SS from 147 X. citri (encoded by plasmid pXAC64), which was proposed to be involved in conjugation due to 8 148 neighbouring relaxosome genes and oriT site, is located in another branch in the phylogenetic tree, 149 distinctly from the above two systems (S1 Fig) [22] . 150 To investigate the involvement of the S. maltophilia VirB/T4SS in bacterial antagonism, 151 we created a mutant strain lacking the ATPase coupling protein VirD4 (ΔvirD4) and analysed its 152 ability to restrict growth of other species such as E. coli. Different dilutions of an E. coli culture 153 were mixed with a fixed number of S. maltophilia cells and the co-cultures were spotted onto LB-154 agar plates containing the chromogenic substrate X-gal and incubated for 24 h at 30˚C ( Fig 1B) . 155 As only E. coli cells naturally express β-galactosidase, they turn blue while S. maltophilia cells are 156 yellow. Growth of E. coli was inhibited by S. maltophilia wild-type, but not by the ΔvirD4 strain 157 ( Fig 1B) . The phenotype of S. maltophilia ΔvirD4 could be restored by complementing the strain 158 with a plasmid encoding VirD4 (smlt3008) under the control of the P BAD promoter (ΔvirD4 159 virD4 C smlt ) ( Fig 1B) . This plasmid promotes low expression levels under non-inducing conditions 160 (no L-arabinose) in Stenotrophomonas and is usually sufficient for complementation. 161 Interestingly, transformation of S. maltophilia ΔvirD4 strain with a plasmid encoding VirD4 from 162 X. citri (xac2623) (ΔvirD4 virD4 C xac ) also restored the phenotype, indicating that these proteins 163 are functionally redundant ( Fig 1B) . 164 To analyse bacterial antagonism at shorter time-points, we measured E. coli cell lysis after Table) . All these putative X-Tfes 205 were identified using searches with the XVIPCDs from at least seven different X. citri X-Tfes (S1 206   Table) . Amino acid sequence alignment of C-terminal XVIPCDs from Stenotrophomonas X-Tfes like hydrolases and proteins with peptidoglycan binding domains ( Fig 3A) . Three of these effectors 214 (smlt2990, smlt2992 and smlt3024) are encoded by genes very close to the S. maltophilia virB 215 locus (genes smlt2997 to smlt3008), further illustrating the link of these effectors with the T4SS.
216
It is interesting to note that six of the identified putative Stenotrophomonas T4SS effectors do not 11 217 display any known protein domain that could indicate the mechanism mediating the antibacterial 218 toxicity (smlt0113, smlt0332, smlt0500, smlt0502, smlt0505, smlt3024) (Fig 3) . To validate our 219 findings and obtain further insight regarding the function of the effectors with domains of unknown 220 function, we selected the products of the smlt3024 gene and its upstream, putatively co-transcribed, 221 partner (smlt3025) for further characterization. annotated either as hemolysin/hemolysin-related or as hypothetical proteins (S1B Table) .
228
However, none of these proteins contain a domain similar to any annotated domain in the Pfam 229 database [35] . In its genomic context, smlt3024 seems to be organized in an operon downstream 230 to two genes encoding for its putative cognate immunity protein (smlt3025) and another small 231 protein containing a helix-turn-helix (HTH) domain annotated as a putative transcriptional 232 regulator (smlt3026) ( Fig 4A) .
233
To determine whether Smlt3024 is indeed an effector secreted via the S. maltophilia T4SS, was co-incubated with E. coli (Figs 4B and 4C) , while no increase was detected when S. 241 maltophilia ΔvirD4 was co-incubated with E. coli (Figs 4B and 4C) . In addition, no increase in 242 signal intensity could be detected when S. maltophilia FLAG-Smlt3024 was incubated without 243 target E. coli cells ( Fig 4B) . SDS-PAGE of total protein extracts followed by western blot with 244 anti-FLAG antibody showed that both S. maltophilia wild-type and ΔvirD4 strains were expressing 245 similar levels of FLAG-Smlt3024 (S2 Fig) . These results show that secretion of Smlt3024 is 246 dependent on contact with a target cell and on a functional T4SS.
247
To assess whether Smlt3025 is the cognate immunity protein of Smlt3024, we analysed 248 whether these proteins could interact by expressing and purifying full-length Smlt3024 and a 249 soluble version of Smlt3025 (amino acid residues 86-333), lacking its N-terminal signal peptide.
250
Complex formation was analysed using size exclusion chromatography coupled to multiple-angle 251 light scattering (SEC-MALS) ( Fig 4E) . The MALS analysis calculated average masses for . When a mixture of these proteins was analysed by SEC-MALS followed by SDS-PAGE, a 255 new peak appeared containing both Smlt3024 and Smlt3025 86-333 with an average molecular mass 256 calculated by MALS of 74.2 kDa, suggesting that a stable 1:1 complex (theoretical mass of 77 257 kDa) was formed between Smlt3024 and Smlt3025 86-333 ( Fig 4E) .
258
If Smlt3024 is indeed a toxic effector secreted by the S. maltophilia T4SS, then we would 
278
To gather further insight on the mechanism by which Smlt3024 could induce toxicity, we 279 decided to perform time-lapse microscopy to evaluate growth and morphology of individual E. 280 coli cells carrying the empty pBRA or pBRA-pelB-smlt3024 plasmids. E. coli carrying the empty 281 plasmid incubated on LB-agar with 0.2% L-arabinose ( Fig 4G and to analyse the ability of mutant strains lacking a functional T4SS to compete with oral and nasal 320 microbiota during infection of susceptible model organisms [43, 44] .
321
The new effector/immunity protein (X-Tfe/X-Tfi) pairs identified in this study expand our 322 knowledge on the different effector proteins promoting target-cell toxicity mediated by T4SSs. 
385
The pBRA construct encoding full-length X. citri virD4/XAC2623 was reported previously [6] .
386
For secretion assays, the full-length sequence of smlt3024 was cloned into pBRA vector, including 387 a FLAG tag on its N-terminus and transformed into S. maltophilia wild-type and ΔvirD4. Plasmids terminal pelB sequence) after the pelB-smlt3024 construct was transferred to pBRA using Gibson 395 assembly. For the immunity protein smtl3025, three different constructs were cloned in pEXT22
396
[57]: one starting at the annotated start-codon and two starting at two downstream putative start- were normalized to those obtained for the S. maltophilia wild-type strain. 
